We are live on ! Find out more
ONCY

ONCOLYTICS BIOTECH INC
ONCY

Delisted

ONCY was delisted on the 4th of November, 2015.

Back to rankings

1 hedge funds and large institutions have $0 invested in ONCOLYTICS BIOTECH INC in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less capital invested

Capital invested by funds: $1K → $0 (-$1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GT
Glenmede Trust
Pennsylvania
-$1K

ONCY Hedge Fund Activity: Q4 2017 in Review

1 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in ONCOLYTICS BIOTECH INC (ONCY) for Q4 2017, worth a combined $0 — down 100% from $1K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ONCY and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Glenmede Trust, exiting entirely with an estimated $1K sold.

  • 1 institutional investor held ONCOLYTICS BIOTECH INC (ONCY) as of Q4 2017, down from 2 in Q3 2017.
  • Funds reported $0 of ONCOLYTICS BIOTECH INC stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new ONCOLYTICS BIOTECH INC positions in Q4 2017 and 1 closed out, a net change of -1 holder.
  • The largest ONCOLYTICS BIOTECH INC seller in Q4 2017 was Glenmede Trust, an estimated $1K sold.

Based on aggregated 13F filings for Q4 2017.